A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy
Neurology2017Vol. 89(17), pp. 1811–1820
Citations Over TimeTop 10% of 2017 papers
Ronald G. Victor, H. Lee Sweeney, Richard S. Finkel, Craig M. McDonald, Barry J. Byrne, Michelle Eagle, Nathalie Goemans, Krista Vandenborne, Alberto Dubrovsky, Haluk Topaloğlu, M. Carrie Miceli, Pat Furlong, John Landry, Robert M. Elashoff, David A. Cox, For the Tadalafil DMD Study Group, Tadalafil DMD Study Group, Hoda Abdel‐Hamid, Susan Apkon, Richard J. Barohn, Е. Д. Белоусова, Enrico Bertini, John F. Brandsema, Claudio Bruno, W. Bryan Burnette, Russell J. Butterfield, Barry Byrne, Craig Campbell, Jose Carlo, Jong‐Hee Chae, Saleel Chandratre, Giacomo P. Comi, Anne M. Connolly, Imelda J. M. de Groot, Nicolas Deconinck, Joseph Dooley, Alberto Dubrovsky, Julien Durigneux, Erika Finanger, Richard S. Finkel, Loren M. Frank, Nathalie Goemans, Amy Harper, Ayako Hattori, Özlem Hergüner, Susan T. Iannaccone, Joanne Janas, Yuh‐Jyh Jong, Janbernd Kirschner, Hirofumi Komaki, Nancy L. Kuntz, Wang‐Tso Lee, Edward Leung, Jean K. Mah, Katherine D. Mathews, Craig M. McDonald, Eugenio Mercuri, Hugh J. McMillan, Wolfgang Mueller‐Felber, Adolfo López de Munaín, Akinori Nakamura, E. Niks, Katsuhisa Ogata, Samuel Ignacio Pascual Pascual, Elena Pegoraro, Yann Péréon, Ben Renfroe, Ratna Bhavaraju Sanka, Jens Schallner, Ulrike Schara, Kathryn Selby, Isabel Illa Sendra, Laurent Servais, Edward C. Smith, Susan Sparks, Haluk Topaloğlu, R Medina Victor, Juan J. Vílchez, Matthew Wicklund, Ekkehard Wilichoswki, Brenda Wong
Abstract
This study provides Class I evidence that tadalafil does not slow ambulatory decline in 7- to 14-year-old boys with Duchenne muscular dystrophy.
Related Papers
- → Tadalafil for the treatment of pulmonary arterial hypertension(2009)41 cited
- [Tadalafil for erectile dysfunction: efficacy evaluation].(2009)
- → Causes of tadalafil failure and rechallenging treatment(2012)
- → Faculty Opinions recommendation of Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.(2013)
- → Faculty Opinions recommendation of Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.(2013)